ArticleCancers2025
High Tumoral CD24 Expression and Low CD3
Hazem Ghebeh, Jumanah Y Mirza, Shamayel F Mohammed, Hatim A Khoja, Mohammad Anas Dababo, Muruj E Tukruni, Muhammad S Anwar, Mohammed Aldehaim, Nasser Al-Rajhi
Abstract read
In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Hazem GhebehCell Therapy and Immunobiology Department, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.ORCID 0000-0002-3297-3996 Jumanah Y MirzaCell Therapy and Immunobiology Department, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
Shamayel F MohammedDepartment of Pathology, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
Hatim A KhojaDepartment of Pathology, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
Mohammad Anas DababoDepartment of Pathology, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
Muruj E TukruniCell Therapy and Immunobiology Department, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
Muhammad S AnwarDepartment of Medical Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
Mohammed AldehaimDepartment of Radiation Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.ORCID 0009-0004-6470-3589 Nasser Al-RajhiDepartment of Radiation Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.ORCID 0000-0001-5608-6091 Funding
King Faisal Specialist Hospital & Research Centre 2150-013
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
CD3nasopharyngeal carcinomatumor-infiltrating lymphocytes
Identifiers
PMID40647395
PMCPMC12249431
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390